Distinguished innovator in genomics joins the scientific advisory board of predictive oncology

Eagan, minn., dec. 13, 2022 (globe newswire) -- predictive oncology inc. (nasdaq: poai) today announced the appointment of marc malandro, ph.d., to the company's scientific advisory board where he will serve alongside other key thought leaders in their respective fields to guide the company's scientific initiatives and growth strategy.

POAI Ratings Summary

POAI Quant Ranking